Orphazyme (Denmark) Probability of Future Stock Price Finishing Over 1,006
| ORPHA Stock | DKK 915.00 9.90 1.07% |
Orphazyme |
Orphazyme Target Price Odds to finish over 1,006
The tendency of Orphazyme Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 915.00 | 90 days | 915.00 | about 72.98 |
Based on a normal probability distribution, the odds of Orphazyme to move above the current price in 90 days from now is about 72.98 (This Orphazyme AS probability density function shows the probability of Orphazyme Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Orphazyme AS has a beta of -0.73. This indicates as returns on the benchmark increase, returns on holding Orphazyme are expected to decrease at a much lower rate. During a bear market, however, Orphazyme AS is likely to outperform the market. Additionally Orphazyme AS has an alpha of 0.4277, implying that it can generate a 0.43 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Orphazyme Price Density |
| Price |
Predictive Modules for Orphazyme
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Orphazyme AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Orphazyme Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Orphazyme is not an exception. The market had few large corrections towards the Orphazyme's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Orphazyme AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Orphazyme within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.43 | |
β | Beta against Dow Jones | -0.73 | |
σ | Overall volatility | 146.29 | |
Ir | Information ratio | 0.05 |
Orphazyme Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Orphazyme for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Orphazyme AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Orphazyme AS had very high historical volatility over the last 90 days | |
| The company reported the revenue of 36.19 M. Net Loss for the year was (626.54 M) with profit before overhead, payroll, taxes, and interest of 36.19 M. | |
| Orphazyme AS has accumulated about 726.93 M in cash with (602.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.8. |
Orphazyme Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Orphazyme Stock often depends not only on the future outlook of the current and potential Orphazyme's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orphazyme's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 35 M |
Orphazyme Technical Analysis
Orphazyme's future price can be derived by breaking down and analyzing its technical indicators over time. Orphazyme Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orphazyme AS. In general, you should focus on analyzing Orphazyme Stock price patterns and their correlations with different microeconomic environments and drivers.
Orphazyme Predictive Forecast Models
Orphazyme's time-series forecasting models is one of many Orphazyme's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Orphazyme's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Orphazyme AS
Checking the ongoing alerts about Orphazyme for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Orphazyme AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Orphazyme AS had very high historical volatility over the last 90 days | |
| The company reported the revenue of 36.19 M. Net Loss for the year was (626.54 M) with profit before overhead, payroll, taxes, and interest of 36.19 M. | |
| Orphazyme AS has accumulated about 726.93 M in cash with (602.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.8. |
Other Information on Investing in Orphazyme Stock
Orphazyme financial ratios help investors to determine whether Orphazyme Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orphazyme with respect to the benefits of owning Orphazyme security.